Galectin-3 acts as an angiogenic switch to induce tumor angiogenesis via Jagged-1/Notch activationSofia Nascimento dos Santos, Emerson Soares Bernardes, Helen Sheldon et al.|Oncotarget|2017Cited by 82
O-glycan sialylation alters galectin-3 subcellular localization and decreases chemotherapy sensitivity in gastric cancerSofia Nascimento dos Santos, Emerson Soares Bernardes, Marcelo Dias‐Baruffi et al.|Oncotarget|2016Cited by 60
Galectin‐3 disruption impaired tumoral angiogenesis by reducing VEGF secretion from TGF<i>β</i>1‐induced macrophagesCamila Maria Longo Machado, Roger Chammas, Fu‐Tong Liu et al.|Cancer Medicine|2014Cited by 48
Lack of galectin-3 increases Jagged1/Notch activation in bone marrow-derived dendritic cells and promotes dysregulation of T helper cell polarizationMarise Lopes Fermino, Emerson Soares Bernardes, L. Sebastian D. Dylon et al.|Molecular Immunology|2016Cited by 31
Lack of galectin-3 modifies differentially Notch ligands in bone marrow and spleen stromal cells interfering with B cell differentiationFelipe Leite de Oliveira, Márcia C. El-Cheikh, Thayse Pinheiro da Costa et al.|Scientific Reports|2018Cited by 25